Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
diabetic retinopathy
Pharma
Roche's eye disease meds Vabysmo, Susvimo show extended efficacy
Roche showed positive long-term data for its eye disease treatments Susvimo and Vabysmo.
Kevin Dunleavy
Jul 18, 2024 11:37am
Roche blasts 'act of counterfeiting' for cancer drug in Pakistan
Sep 25, 2023 2:27pm
FDA approves Regeneron’s HD Eylea, triggering battle with Roche
Aug 21, 2023 11:01am
FDA grants priority review to Regeneron's high-dose Eylea filing
Feb 23, 2023 10:05am
FDA approves Regeneron's Eylea for retinopathy of prematurity
Feb 9, 2023 11:18am
Regeneron's Eylea gains priority review in infant retinopathy
Oct 12, 2022 9:36am
